This HRSA-funded Opioid ECHO program ends on August 31, 2018. We want to give you as many opportunities to attend sessions as possible in the time remaining. To that end, we are opening the five Opioid ECHO hubs to all registered participants.
If you have not yet registered, click on Register Now and follow the instructions.
You can view the schedule of sessions and lectures here.
This ECHO provides training in opioid addiction treatment at no cost, delivered right to your clinic, with a variety of bi-weekly schedules to choose from. We serve federally-qualified health centers, with a special focus on those that received the Substance Abuse Service Expansion awards. Using simple videoconferencing technology, healthcare teams connect to a community of learners which offers:
- Free continuing education credit
- For NPs and PAs, Credit toward your 16-hour DATA waiver requirement (click HERE for more details)
- Opportunity to present actual patient cases, in a de-identified format, and receive specialty input
- Addiction treatment training, including management of naloxone/buprenorphine (e.g. Suboxone) and injectable naltrexone (e.g. Vivitrol)
- Access to a virtual learning community for access to treatment guidelines, tools, and patient resources
- Certificate of training completion from ECHO and the American Society of Addiction Medicine
Opioid Addiction Treatment ECHO focuses on providers and primary care team members.
Learn more about the Opioid Addiction Treatment ECHO
|To view the June 23rd Intro Session on Project ECHO’s Opioid Addiction Treatment Program targeted for HRSA-funded health centers click the image to the right.|
Contact Us: 505-925-2406 OpioidECHO@salud.unm.edu
This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under contract number HHSH250201600015C. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government